Latest News

Imaging studies may predict tumor response to anti-angiogenic drugs

Advanced imaging techniques may distinguish which patients' tumors will respond to treatment with anti-angiogenic drugs and which will not. In patients newly diagnosed with the dangerous brain tumor glioblastoma, those for whom treatment with the anti-angiogenic drug cediranib rapidly 'normalized' abnormal blood vessels around their tumors and increased blood flow within tumors survived significantly longer than did patients in whom cediranib did not increase blood flow.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Commonly available blood-pressure medication prevents epilepsy after severe brain injury

  • Critical new protein complex involved in learning, memory

  • Teachers' scare tactics may lead to lower exam scores

  • Financial incentives help economically-disadvantaged pregnant smokers quit, improve fetal growth

  • Regulating legal marijuana could be guided by lessons from alcohol, tobacco, study says

  • Want to quit smoking? New study says try 'self-expanding' activities

  • Mentor programs harm, more than help first-year teachers

  • Physicists push new Parkinson's treatment toward clinical trials

  • First brain images of African infants enable research into cognitive effects of nutrition

  • New way to enhance nerve growth following injury discovered

  •